Publicaciones (28) Publicaciones de Jacinto Ramos González

2023

  1. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  2. Impact of Air Pollution on Asthma: A Scoping Review

    Open Respiratory Archives, Vol. 5, Núm. 2

  3. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

  4. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

  5. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9

  3. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

2020

  1. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7

2019

  1. Exacerbación asmática

    Manual terapéutico (Ediciones Universidad de Salamanca), pp. 604-607

  2. Exacerbación de enfermedad pulmonar obstructiva crónica (EPOC)

    Manual terapéutico (Ediciones Universidad de Salamanca), pp. 619-626

  3. Insuficiencia respiratoria aguda

    Manual terapéutico (Ediciones Universidad de Salamanca), pp. 608-612

  4. Tromboembolismo pulmonar (TEP)

    Manual terapéutico (Ediciones Universidad de Salamanca), pp. 585-593

  5. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study

    Respiratory Medicine, Vol. 151, pp. 49-54

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2014

  1. An Alternative Method for Predicting the Risk of Postoperative Complications in Lung Resection

    Archivos de Bronconeumologia, Vol. 50, Núm. 3, pp. 87-92

  2. Clinical benefits of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

    Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 34, Núm. 5, pp. 355-359

2010

  1. A qualidade de vida relacionada com a saúde de doentes com doença pulmonar obstrutiva crónica e asma avaliada pelo SGRQ

    Revista Portuguesa de Pneumologia, Vol. 16, Núm. 4, pp. 543-558

2007

  1. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

    Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72

  2. Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: Results of the European Community Respiratory Health Survey I

    Clinical and Experimental Allergy, Vol. 37, Núm. 5, pp. 780-787